191 related articles for article (PubMed ID: 7535824)
1. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
4. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.
Choppin J; Martinon F; Connan F; Gomard E; Levy JP
J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
6. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.
Couillin I; Connan F; Culmann-Penciolelli B; Gomard E; Guillet JG; Choppin J
Eur J Immunol; 1995 Mar; 25(3):728-32. PubMed ID: 7705402
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
8. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
9. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
12. Who is right? Or, how to judge the disagreement about HLA restriction of Nef peptides.
Hunziker IP; Cerny A; Pichler WJ
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):921-4. PubMed ID: 9686637
[No Abstract] [Full Text] [Related]
13. Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef.
Goulder PJ; Edwards A; Phillips RE; McMichael AJ
AIDS; 1997 Mar; 11(4):536-8. PubMed ID: 9084804
[No Abstract] [Full Text] [Related]
14. An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules.
Culmann B; Gomard E; Kiény MP; Guy B; Dreyfus F; Saimot AG; Sereni D; Lévy JP
Eur J Immunol; 1989 Dec; 19(12):2383-6. PubMed ID: 2481593
[TBL] [Abstract][Full Text] [Related]
15. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity.
Meyerhans A; Dadaglio G; Vartanian JP; Langlade-Demoyen P; Frank R; Asjö B; Plata F; Wain-Hobson S
Eur J Immunol; 1991 Oct; 21(10):2637-40. PubMed ID: 1717289
[TBL] [Abstract][Full Text] [Related]
16. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
17. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.
Safrit JT; Lee AY; Andrews CA; Koup RA
J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505
[TBL] [Abstract][Full Text] [Related]
18. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.
Choppin J; Martinon F; Connan F; Pauchard M; Gomard E; Levy JP
J Immunol; 1991 Jul; 147(2):575-83. PubMed ID: 1712812
[TBL] [Abstract][Full Text] [Related]
19. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
Motozono C; Yanaka S; Tsumoto K; Takiguchi M; Ueno T
J Immunol; 2009 May; 182(9):5528-36. PubMed ID: 19380801
[TBL] [Abstract][Full Text] [Related]
20. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
